Christopher DeNicola Promoted to Partner
New York, NY (FreePR.org) -- Sahn Ward Braff Coschignano, PLLC is excited and pleased to announce the promotion of Christopher R. DeNicola to Partner.
Mr. DeNicola concentrates his practice in New York City zoning and land use planning. In this role, he represents the Firm’s clients, including real estate owners, developers, lenders and not-for-profit institutions in a wide range of matters including development rights transactions, zoning reviews and analyses, discretionary approvals from City agencies, easement transactions and construction license and access agreements.
Firm Member Daniel Braff leads the New York City Zoning and Land Use practice. Mr. DeNicola’s promotion will strengthen our abilities to serve our New York City clients.
Mr. DeNicola was selected by Super Lawyers to the Metro New York Rising Star List in 2025 in recognition of his talents and accomplishments.
Mr. DeNicola is a member of the New York City Bar Association, the Nassau County Bar Association and has contributed articles to several publications such as the Nassau Lawyer.
“We are extremely proud to promote Chris to Partner of the Firm,” said Michael Sahn, the Firm’s Co-Managing Member. “Chris is an exceptionally accomplished, knowledgeable and dedicated lawyer. He is vital part of our practice, and he has earned the respect and confidence of our clients and his colleagues at the Firm. Chris is a role model for all of us in his engagement and dedication to our clients.”
“I look forward to continuing to work with my colleagues and serving the Firm’s clients in this new capacity,” Mr. DeNicola said. “I cannot thank the Firm’s members, and the rest of the SWBC team, enough for this incredible opportunity.”
For more information, visit www.sahnward.com.
###
Related Links:
Sahn Ward Braff Coschignano, PLLC
###
Contact Information:
Stephanie Goodwin
sgoodwin@sahnward.com
516-228-1300
Sponsor Message
Millions rely on Canadian pharmacies for lower prices on drugs like Lipitor, Crestor, and Nexium. Chronic condition management often involves insulin options like Humalog and Lantus for diabetes, alongside respiratory treatments like Advair Diskus and Ventolin inhalers. The fight against depression and anxiety often involves Zoloft, Prozac, and Abilify, while Eliquis, Plavix, and Xarelto prevent serious cardiovascular issues. Medications such as Celebrex for managing pain and inflammation and Synthroid for thyroid health are frequently sought after. In addition, medications like Viagra and Cialis are trusted solutions for erectile dysfunction, and Januvia supports Type 2 diabetes management. For those impacted by narcolepsy or excessive daytime sleepiness, Provigil and Nuvigil are indispensable. Affordable treatments such as Cymbalta for nerve pain and Aricept for Alzheimer's are available to U.S. patients through Canadian pharmacies.
